News for Viveve Medical, Inc. (VIVE)

/PRNewswire/ -- Crown Aesthetics ("Crown"), a division of Crown Laboratories, Inc., announced today that it is expanding further into the Asia Pacific ("APAC")...

NEW YORK, Jan. 23, 2023 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of Schmitt Industries, Inc....

NEW YORK, Jan. 23, 2023 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of Schmitt Industries, Inc. Schmitt Industries, Inc.'s common stock was suspended on January 17,

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 1.14%

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning higher on Tuesday.

U.S. stocks traded mostly lower midway through trading, with the Dow Jones dropping over 300 points on Tuesday.

Viveve Medical Inc (NASDAQ: VIVE) announced topline results from the U.S. Pivotal PURSUIT clinical trial evaluating Viveve treatment for stress urinary incontinence (SUI) in women. The study did not meet its primary endpoint of achieving a statistically significant higher proportion of patients experiencing more than a 50% reduction in urine leakage compared to baseline on the standardized 1-hour Pad Weight Test at 12 months post-treatment in the active treatment versus the sham control group. A

Viveve Medical (VIVE) treatment for female stress urinary incontinence ((SUI)) failed a pivotal trial and the company has decided to seek strategic alternatives and delist from...

Operator: Good afternoon. Welcome to the Viveve Third Quarter 2022 Financial Results and Corporate Update Conference Call. Please note that this event is recorded. I'll turn the call over to Ms.

Gainers

A whopping number of 13F filings filed with U.S. Securities and Exchange Commission has been processed by Insider Monkey so that individual investors...

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 4) ...

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 14) 10X ...

Today's Daily Dose brings you news about Lexicon's regulatory update on Sotagliflozin in heart failure; FDA approval of Pfizer's XALKORI in a new indication; Bicycle's pipeline progress update and Organogenesis' progress in knee osteoarthritis trial.

Toward the end of trading Thursday, the Dow traded up 0.24% to 31,135 while the NASDAQ rose 0.27% to 13,164.28. The S&P also rose, gaining 0.08% to ...

Midway through trading Thursday, the Dow traded up 0.42% to 31,189.88 while the NASDAQ rose 0.35% to 13,175.48. The S&P also rose, gaining 0.15% to ...

Viveve Medical Inc is a women\’s sexual health company focused on the commercialization of a non-surgical, non-ablative medical device that remodels collagen ...

Following the market opening Thursday, the Dow traded up 0.43% to 31,195.15 while the NASDAQ rose 0.53% to 13,199.16. The S&P also rose, gaining 0.32% ...

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 12) ...